The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SMART: A phase II study of sacituzumab govitecan (SG) with or without atezolizumab immunotherapy in rare genitourinary (GU) tumors such as small cell, adenocarcinoma, and squamous cell bladder/urinary tract cancer, renal medullary carcinoma (RMC) and penile cancer.
 
Andre Rashad Kydd
No Relationships to Disclose
 
Elias Chandran
No Relationships to Disclose
 
Nicholas I. Simon
No Relationships to Disclose
 
Saad Omar Atiq
No Relationships to Disclose
 
Tzu-fang Wang
No Relationships to Disclose
 
Lisa M. Cordes
No Relationships to Disclose
 
Elizabeth Smith
No Relationships to Disclose
 
Matthew Lindsley
No Relationships to Disclose
 
Lisa Ley
No Relationships to Disclose
 
Salah Boudjadi
No Relationships to Disclose
 
Scot Anthony Niglio
No Relationships to Disclose
 
Sally Weng
No Relationships to Disclose
 
Ian Stukes
No Relationships to Disclose
 
Md Shahid Sarwar
No Relationships to Disclose
 
Rouf Banday
No Relationships to Disclose
 
Dilara Akbulut
No Relationships to Disclose
 
Sandeep Gurram
No Relationships to Disclose
 
Bernadette Redd
Consulting or Advisory Role - 2020DX (I); Abbvie (I)
 
Seth M. Steinberg
No Relationships to Disclose
 
Andrea B Apolo
No Relationships to Disclose